dioscin has been researched along with Invasiveness, Neoplasm in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ao, W; Chen, B; Hou, Y; Ke, J; Liang, Q; Wang, K; Wei, X; Xiao, J; Zhan, Y; Zhou, S; Zhu, P | 1 |
Ali, Z; Aumsuwan, P; Avula, B; Dasmahapatra, AK; Helferich, WG; Katzenellenbogen, BS; Khan, IA; Khan, SI; Shariat-Madar, Z; Walker, LA | 1 |
Han, X; Peng, J; Qi, Y; Si, L; Wang, C; Xu, L; Xu, Y; Yin, L; Zheng, L | 1 |
3 other study(ies) available for dioscin and Invasiveness, Neoplasm
Article | Year |
---|---|
Dioscin Inhibits the Invasion and Migration of Hepatocellular Carcinoma HepG2 Cells by Reversing TGF-β1-Induced Epithelial-Mesenchymal Transition.
Topics: Cell Movement; Cell Proliferation; Diosgenin; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; Neoplasm Invasiveness; p38 Mitogen-Activated Protein Kinases; Pentacyclic Triterpenes; Signal Transduction; Transforming Growth Factor beta1 | 2019 |
The anticancer potential of steroidal saponin, dioscin, isolated from wild yam (Dioscorea villosa) root extract in invasive human breast cancer cell line MDA-MB-231 in vitro.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Dioscorea; Diosgenin; Dose-Response Relationship, Drug; Humans; MCF-7 Cells; Neoplasm Invasiveness; Phytosterols; Plant Extracts; Plant Roots; Saponins; Treatment Outcome | 2016 |
Dioscin suppresses human laryngeal cancer cells growth via induction of cell-cycle arrest and MAPK-mediated mitochondrial-derived apoptosis and inhibition of tumor invasion.
Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cytochromes c; Diosgenin; DNA Damage; Humans; Laryngeal Neoplasms; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mitochondria; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness; Protein Kinase Inhibitors; Reactive Oxygen Species | 2016 |